Home Analyst Ratings Stifel initiates Beam Therapeutics at Hold rating with $84 price target

Stifel initiates Beam Therapeutics [BEAM] at Hold rating with $84 price target

Stifel launched its Beam Therapeutics [BEAM] rating to the equivalent of Hold and assigned the price target of $84, in a research note dated 2021-01-06. That figure represents around a -0.08% premium from where the company’s shares closed on Tuesday. Some new analysts also started their coverage, with Wedbush’s analysts assigning the shares to “an Outperform” rating in a research note to investors issued in early March. Meanwhile, JP Morgan had launched its coverage on BEAM with “an Overweight”, in a research note produced for clients March 02, 2020. In addition, Jefferies launched coverage on March 02, 2020. The research firm rated BEAM “a Buy”.

Get the hottest stocks to trade every day before the market opens 100% free. Click here now. 

Is Beam Therapeutics Inc. [NASDAQ:BEAM] a Good Buy Right Now?

It should be noted that BEAM technical indicators for short, intermediate as well as long term progress have placed an overall average of 100% as Buy. The average signal changed from 100% Buy in the last week and compares with 100% Buy in the past month. Data from Beam Therapeutics Inc.’s Trend Spotter indicated that the signals were Strongest. The stock current average is 1.16 million shares in the past 20 days and the short term average signal indicates a 100% Buy. In the last 50 days, the average trading volume was 0.83 million shares while the medium term average advocated for 100% Buy. The average long-term signal stands at 100% Buy and the 100-day average volume stands at 0.75 million shares.


The 2021 Backdoor Crypto Portfolio (free)

Even if you’re not actively in crypto, you deserve to know what’s actually going on...

Because while leading assets such as Bitcoin (BTC) and Ethereum (ETH) are climbing in value, a select group of public “crypto stocks” are surging right along with them. More importantly, these stocks are outpacing the returns these leading crypto assets aren already producing.

Click here to get the full story… along with our long list of backdoor Bitcoin strategies. It’s free.

Sponsored


BEAM Price Performance

On Wall Street, Beam Therapeutics Inc. [NASDAQ:BEAM] finished Tuesday’s session up 1.12% at $84.07. The stock went up to $86.60 at the same session while its lowest single day price was $80.00. In the last five days, it saw a fall of about -12.09%, Beam Therapeutics Inc. shares gained by almost 2.98% since the beginning of the year. However, the share price has dropped to as low as -16.47% below its one year high.

BEAM Stock Support And Resistance Levels

On the 24-hour scale, the immediate backing is perceived around 80.51 level, and in case of violation of this particular level, it will cause more drop to 76.96 level. On the upper level, 90.16 is still the key resistance. The stock may increase to the subsequent resistance at 87.11. The Relative Strength Index (RSI) pinned on the 14-day chart is 61.06, implying a neutral technical stance while the MACD stands at -0.34, meaning price will decrease in the next trading period. Percent R indicator moved to 48.06%, implying low price movement. Stochastic %K at 48.69% suggest selling the stock.

What is the short interest in Beam Therapeutics Inc.?

Short interest in the Beam Therapeutics Inc. stock has surged, increasing by 0.44 million shares to total 3.26 million shares on Dec 14, 2020. The interest had seen shares on Nov 12, 2020 stand at 3.7 million, data from Yahoo Finance shows. The decrease of -13.5% suggests the stock saw some decreased bullish sentiment. The stock’s days to cover (short ratio) moved to while the shorted shares account for just 7.83% of the overall float for the stock.

Get the hottest stocks to trade every day before the market opens 100% free. Click here now. 

Beam Therapeutics Inc.’s Biggest Shareholders: Who Owns Beam Therapeutics Inc. [BEAM]?

Filings by Temasek Holdings Pte Ltd. showed that the firm now holds a total of 3,354,641 shares or roughly 5.91% of the outstanding BEAM shares. This means their shares have reduced by 0 from the 3,354,641 the investor reportedly held in its prior 13-F filing. With the conclusion of the sale, Redmile Group LLC updated its stake to be worth $166,363,100. Details in the latest 13F filings reveal that Hillhouse Capital Advisors Ltd. disposed of their 0.00% stake valued at $148,320,150 while The Vanguard Group, Inc. added theirs at $108,387,050. During the last quarter, Hillhouse Capital Advisors Ltd. liquidated 0 of its shares in Beam Therapeutics Inc. while The Vanguard Group, Inc. bought 1,042,138 shares. The BlackRock Fund Advisors’s holdings currently number 1,839,808 shares at $154672658.56. According to the firm’s last 13F report, FIL Investment Advisors shares in the company at filing stood at 816,116 shares, roughly $40,805,800.

Get The Best Stocks To Trade Every Day!

Join now to get the NewsHeater.com pre-market morning brief 100% free

Must Read

ReTo Eco-Solutions Stock Drops Pre-Market Today: Why?

The manufacturer and distributor of construction material ReTo Eco-Solutions Inc. (NASDAQ: RETO) has been experiencing a fall of more than 10% in pre-market session...

What do you think of the sentiment expressed? MMEX Resources Corporation [MMEX]?

The share price of MMEX Resources Corporation has decreased -16.98% to $0.0044 on Wednesday with a day range of $0.0104 to $0.0041. In the...

Sunesis Pharmaceuticals (SNSS) stock price has skyrocketed over 20% in intraday: Things you need to know.

The shares of Sunesis Pharmaceuticals (SNSS), a biopharmaceutical company that aims to treat hematologic and solid cancers, have skyrocketed after the Oppenheimer analyst Hartaj...

For What Reason, Bemax Inc (BMXC) Stock Climbed 5%?

A stock of Bemax Inc surged 5.41% in the last session, closing at $0.0039. The 30-day average volume for the stock was 204.32M...

Why R. R. Donnelley (RRD) Stock Trading Higher In Pre-Market Trades? Here Is The Reason

R.R. Donnelley & Sons Company (RRD) stock has been surging 37.92% pre-market to $3.31 as of 08:18 a.m. EST, following the release of the...

Why Pandion Therapeutics [PAND] Stock Skyrocketing Pre-Market Today?

Pandion Therapeutics Inc. (NASDAQ: PAND) stock has been skyrocketing in pre-market trades today following news of a definitive agreement of acquisition. As of 08:50...

ReTo Eco-Solutions Stock Drops Pre-Market Today: Why?

The manufacturer and distributor of construction material ReTo Eco-Solutions Inc. (NASDAQ: RETO) has been experiencing a fall of more than 10% in pre-market session...

What do you think of the sentiment expressed? MMEX Resources Corporation [MMEX]?

The share price of MMEX Resources Corporation has decreased -16.98% to $0.0044 on Wednesday with a day range of $0.0104 to $0.0041. In the...

Related News

KeyBanc reiterates Magna International [MGA] rating to Overweight and sets new price target at $86

KeyBanc maintained its Magna International rating to the equivalent of Overweight but changed the price target to $86.0 from $72, in a research...

Jefferies upgrades Medifast [MED] to Buy rating with a $265 price target

Jefferies took its Medifast rating to the equivalent of Buy from Hold, and the price target to $265.0 from $205, in a research...

American Eagle Outfitters [AEO] Upgraded to Outperform at RBC Capital

RBC Capital took its American Eagle Outfitters rating to the equivalent of Outperform from Sector Perform, and the price target to $30.0 from...

KeyBanc reiterates Nike [NKE] rating to Overweight and sets new price target at $180

KeyBanc maintained its Nike rating to the equivalent of Overweight but changed the price target to $180.0 from $174, in a research note...

Raymond James upgrades Atlantic Capital [ACBI] to Outperform

Raymond James took its Atlantic Capital rating to the equivalent of Outperform from Market Perform, in a research note dated 2021-01-25. Other analysts...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Get The Best Stocks To Trade Every Day!

Join now to get the NewsHeater.com pre-market morning brief 100% free

Get The Best Stocks To Trade Every Day!

Join now to get the NewsHeater.com pre-market morning brief 100% free

We do not sell or share your information with anyone.

Get The Best Stocks To Trade Every Day!...100% Free

We do not sell or share your information with anyone.

Get Best Morning Financial Newsletter... 100% Free

Best stocks ideas

Analysts’ Upgrades & Downgrades

Insider Watchlist

Important Earnings

We do not sell or share your information with anyone.